Att H_Published 60d FRN

80506

Federal Register / Vol. 75, No. 245 / Wednesday, December 22, 2010 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued

Stakeholders ................................................................................................................................
Industry leader recommend stores ..............................................................................................
Community leader recommend stores ........................................................................................

Shari Steinberg,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2010–32077 Filed 12–21–10; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30 Day–11–10GX]

Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to [email protected]. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
Persistence of Viable Influenza Virus
in Aerosols—New—National Institute
for Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).

Number of
responses per
respondent

Number of
respondents

Respondents

3
3

30
30

Average
burden per
response
(in hrs)
30/60
30/60

will assist in determining the possible
role of airborne transmission in the
spread of influenza and in devising
measures to prevent it.
Volunteer participants will be
recruited by a test coordinator using a
flyer describing the study. Interested
potential participants will be screened
using a short health questionnaire to
verify that they have influenza-like
symptoms and that they do not have any
medical conditions that would preclude
their participation. Based on a previous
study using similar forms, we estimate
that the health questionnaire will
require about 5 minutes to complete.
Qualified participants who agree to
participate in the study will be asked to
read and sign an informed consent form.
Based on the previous study, we
estimate that the informed consent form
will take about 10 minutes to read and
sign. Once the informed consent form is
signed, the participant will have their
oral temperature measured, two
nasopharyngeal swabs will be collected,
and the participant will be asked to
cough into an aerosol particle collection
system. These steps will take about 25
minutes. The airborne particles
produced by the participant during
coughing will be collected and tested.
There are no costs to the respondents
other than their time. The total
estimated annual burden hours are 84.

Background and Brief Description
The National Institute for
Occupational Safety and Health
(NIOSH) is authorized to conduct
research to advance the health and
safety of workers under Section 20(a) (1)
of the 1970 Occupational Safety and
Health Act. Influenza continues to be a
major public health concern because of
the substantial health burden from
seasonal influenza and the potential for
a severe pandemic. Although influenza
is known to be transmitted by infectious
secretions, these secretions can be
transferred from person to person in
many different ways, and the relative
importance of the different pathways is
not known. The likelihood of the
transmission of influenza virus by small
infectious airborne particles produced
during coughing and breathing is
particularly unclear. The question of
airborne transmission is especially
important in healthcare facilities, where
influenza patients tend to congregate
during influenza season, because it
directly impacts the infection control
and personal protective measures that
should be taken by healthcare workers.
The purpose of this study is to measure
the amount of viable influenza virus in
airborne particles that are produced by
patients when they cough, and the size
and quantity of the particles carrying
the virus. A better understanding of the
amount of potentially infectious
material released by patients and the
size of the particles carrying the virus

srobinson on DSKHWCL6B1PROD with NOTICES

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of respondent

Form

Initial participants (phase 1) ..............
Qualified participants (phase 1) ........

Health questionnaire ........................
Informed Consent form ....................
No form; Time required for testing. ..
Health questionnaire ........................
Informed Consent form ....................
No form; Time required for testing. ..
Health questionnaire ........................
Informed Consent form ....................
No form; Time required for testing. ..

Initial participants (phase 2) ..............
Qualified participants (phase 2) ........
Initial participants (phase 3) ..............
Qualified participants (phase 3) ........

VerDate Mar<15>2010

20:24 Dec 21, 2010

Jkt 223001

PO 00000

Frm 00052

Fmt 4703

Sfmt 4703

Number of
responses per
respondent

44
40
40
44
40
40
44
40
40

E:\FR\FM\22DEN1.SGM

1
1
1
1
1
1
1
1
1

22DEN1

Average
burden per
response
(in hours)
5/60
10/60
25/60
5/60
10/60
25/60
5/60
10/60
25/60

Total burden
hours
4
7
17
4
7
17
4
7
17

Federal Register / Vol. 75, No. 245 / Wednesday, December 22, 2010 / Notices
Dated: December 16, 2010.
Catina Conner,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2010–32076 Filed 12–21–10; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–11–11BF]

Proposed Data Collections Submitted
for Public Comment and
Recommendations

srobinson on DSKHWCL6B1PROD with NOTICES

In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instrument, call 404–639–5960 and send
comments to Carol E. Walker, Acting
CDC Reports Clearance Officer, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30333; or send an e-mail to
[email protected].
Comments are invited on (a) whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have a
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Contact Investigation Outcome
Reporting Forms—New—National
Center for Emerging, Zoonotic and
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).

VerDate Mar<15>2010

20:24 Dec 21, 2010

Jkt 223001

Background and Brief Description
CDC proposes to collect passengerlevel, epidemiologic, demographic, and
health status data from State/local
Health Departments and maritime
operators at the conclusion of contact
investigations of individuals believed to
have been exposed to a communicable
disease during travel. The information
requested by CDC would be obtained by
the health departments or maritime
operators while conducting the contact
investigation according to their
established policies and procedures,
and would be reported to CDC on a
voluntary basis. This information will
assist CDC in fulfilling its regulatory
responsibility to prevent the
importation of communicable diseases
from foreign countries (42 CFR part 71)
and interstate control of communicable
diseases in humans (42 CFR part 70). To
perform these tasks in a streamlined
manner and ensure that all relevant
information is collected in the most
efficient and timely manner possible,
Quarantine Stations use a number of
forms: Contact Investigation Outcome
Reporting Forms: (1) Optional TB Air/
Land Contact Investigation Outcome
Reporting, (2) Optional Measles,
Mumps, or Rubella Air/Land Contact
Investigation Outcome Reporting, (3)
Optional General Air/Land Contact
Investigation Outcome Reporting Form,
(4) Optional TB Maritime Contact
Investigation Outcome Reporting Form,
(5) Optional Measles, Mumps or Rubella
Maritime Contact Investigation Outcome
Reporting Form, (6) Optional General
Maritime Contact Investigation Outcome
Reporting Form.
Section 361 of the Public Health
Service (PHS) Act (42 USC 264)
authorizes the Secretary of Health and
Human Services to make and enforce
regulations necessary to prevent the
introduction, transmission or spread of
communicable diseases from foreign
countries into the United States. The
regulations that implement this law, 42
CFR parts 70 and 71, require
conveyances to report an ‘‘ill person’’ or
any death onboard to authorized
quarantine officers and other personnel
to inspect and undertake necessary
control measures with respect to
conveyances (e.g., airplanes, cruise
ships), persons, and shipments of
animals and etiologic agents in order to
protect the public health. The

PO 00000

Frm 00053

Fmt 4703

Sfmt 4703

80507

notification is made possible by
contacting individuals who may have
been exposed to a communicable
disease during travel and their contacts,
and investigating this exposure so that
the necessary medical or public health
interventions can be implemented.
CDC provides state and local health
departments and maritime conveyance
operators with information to notify and
contact individuals and further
investigate this exposure by contacting
others who may have been potentially
exposed to disease. However, there
currently is no standardized tool or form
to collect pertinent information
regarding the outcome of such
investigations.
To address the need to inform CDC of
additional actions that may be needed to
further protect public health based on
the outcome of the contact
investigations, CDC has developed six
forms to assist health departments and
maritime conveyance operators in
reporting back to CDC. The forms are
specific to the nature of the
investigation; Tuberculosis (TB),
Measles, Mumps, and Rubella or the
General forms specific to other diseases
of public health concern. The purpose
of the forms is the same: To collect
information to help CDC quarantine
officials to fully understand the extent
of disease spread and transmission
during travel and to inform the
development and or refinement of
investigative protocols, aimed at
reducing the spread of communicable
disease.
All six forms collect the following
categories of information: Heath status
of traveler, clinical history including
diagnosis, and interventions related to
exposure.
Respondents are state and local health
departments and maritime conveyance
operators. Respondents will use these
standardized forms to submit data to
CDC for each individual contacted via a
secure means of their choice, e.g., Webbased application, fax or e-mail.
The estimated total burden on the
public, included in the chart below, can
vary a great deal depending on the
number of flights and the number of
individuals identified as contacts that
are assigned to a given health
jurisdiction in the U.S. There is no cost
to respondents other than their time.

E:\FR\FM\22DEN1.SGM

22DEN1